Results 151 to 160 of about 9,378,676 (283)
Clinical evidence, 2002 Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
J, Correia, C A, Hart
openaire +7 more sources
Strategic evaluations and techno-economic networks. Vaccine innovation in the Cuban biotech sector: for public health – or for profits? [PDF]
In this paper the Cuban biotech sector with its highly integrated vaccine industry is analyzed in the perspective of the techno-economic network model of Michel Callon. The paper discusses the strategic evaluations that have been performed in the sector.
Jens Plahte
core
Estimates of the burden of meningococcal disease in Italy: implications for prevention and control
, 2015 Domenico Martinelli +2 more
openalex +1 more source
Invasive Meningococcal Disease, Utah, 1995–2005 [PDF]
, 2007 Rachelle B. Boulton +4 more
openalex +1 more source
Meningococcal disease: changes in epidemiology and prevention
Clinical Epidemiology, 2012 Qiuzhi Chang,1 Yih-Ling Tzeng,2 David S Stephens1–31Department of Epidemiology, Rollins School of Public Health, Emory University, 2Department of Medicine, Emory University School of Medicine, 3Laboratories of Microbial Pathogenesis, Department
Chang Q, Tzeng YL, Stephens DS
doaj
FactSheet : Meningococcal disease [PDF]
New South Wales Public Health Bulletin, 2003 openaire +2 more sources
Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013 [PDF]
, 2014 Carol Chatt +10 more
openalex +1 more source
Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease [PDF]
, 2009 Ondřej Beran +6 more
openalex +1 more source